The Miami International Evidence-based Guidelines on Minimally Invasive Pancreas Resection
2019 · Annals of Surgery · 460 citations
https://doi.org/10.1097/sla.0000000000003590
B
Barish H. Edil
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
273
Papers
17.4K
Citations
69
h-index
135
i10-index
Barish H. Edil is an academic researcher from Oklahoma City University. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Neuroendocrine Tumor Research Advances & Pancreatitis Pathology and Treatment. The author has an h-index of 69, co-authored 233 publications.
ORCID: 0000-0003-1467-9723Papers by this author
worksCancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2–SP1–SAT1 axis
2024 · Nature Cell Biology · 65 citations
https://doi.org/10.1038/s41556-024-01372-4
Tumor-Associated Antigen Expressing Listeria monocytogenes Induces Effective Primary and Memory T-Cell Responses Against Hepatic Colorectal Cancer Metastases
2011 · Annals of Surgical Oncology · 37 citations
https://doi.org/10.1245/s10434-011-2037-0
Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model
2022 · Cancer Letters · 28 citations
https://doi.org/10.1016/j.canlet.2022.215722
The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study
2025 · Annals of Oncology · 9 citations
https://doi.org/10.1016/j.annonc.2024.12.015
Genistein suppresses gallbladder cancer tumorigenesis and progression via downregulating ERBB2 mediated PTK6/AKT/MCM pathway
2022 · Science Bulletin · 3 citations
https://doi.org/10.1016/j.scib.2022.03.011
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat